XML 72 R56.htm IDEA: XBRL DOCUMENT v3.25.0.1
Organization and Summary of Significant Accounting Policies - Narrative (Details)
3 Months Ended 12 Months Ended
May 10, 2024
tranche
May 24, 2018
tranche
shares
Dec. 31, 2024
USD ($)
condition
Jun. 30, 2024
USD ($)
Mar. 31, 2024
USD ($)
Dec. 31, 2023
USD ($)
Sep. 30, 2023
USD ($)
Jun. 30, 2023
USD ($)
Mar. 31, 2023
USD ($)
Dec. 31, 2024
USD ($)
condition
Dec. 31, 2024
USD ($)
condition
Dec. 31, 2024
USD ($)
condition
institution
Dec. 31, 2024
USD ($)
condition
item
Dec. 31, 2024
USD ($)
condition
segment
Dec. 31, 2024
USD ($)
condition
Dec. 31, 2023
USD ($)
Dec. 31, 2022
USD ($)
Dec. 31, 2021
USD ($)
Summary Of Significant Accounting Policy [Line Items]                                    
Decrease in revenue       $ (503,236,000) $ (459,871,000) $ (430,376,000) $ (413,278,000) $ (372,704,000) $ (344,341,000)   $ (2,082,526,000)         $ (1,560,699,000) $ (1,187,143,000)  
Decrease in net income       (41,473,000) (133,352,000) (57,061,000) (61,309,000) (11,514,000) (45,899,000)   (377,034,000)         (175,783,000) (146,930,000)  
Number of depository institutions                       2 2          
Aggregate balances in depository institution accounts     $ 376,800,000             $ 376,800,000 376,800,000 $ 376,800,000 $ 376,800,000 $ 376,800,000 $ 376,800,000      
Number of reportable segments | segment                           2        
Credit losses                     0         0 0  
Restricted cash     11,900,000     2,100,000       11,900,000 11,900,000 11,900,000 11,900,000 $ 11,900,000 11,900,000 2,100,000    
Restricted cash including prepaid expenses and other assets     $ 11,800,000             $ 11,800,000 $ 11,800,000 $ 11,800,000 $ 11,800,000 $ 11,800,000 $ 11,800,000      
Renewal term     5 years             5 years 5 years 5 years 5 years 5 years 5 years      
Termination period                   1 year                
Impairment charges                     $ 0         0 5,300,000  
Goodwill, impairment loss                     0         0 0  
Number of primary revenue sources | item                         2          
Payment due date from date of invoice                   30 days                
Unbilled accounts receivable     $ 5,600,000             $ 5,600,000 5,600,000 $ 5,600,000 $ 5,600,000 $ 5,600,000 $ 5,600,000      
Reserve for expected credit losses     5,609,000     3,966,000       $ 5,609,000 5,609,000 5,609,000 5,609,000 5,609,000 5,609,000 3,966,000 3,630,000 $ 3,349,000
Selling, general and administrative       170,964,000 151,075,000 137,273,000 122,357,000 119,308,000 115,946,000   741,247,000         494,884,000 399,330,000  
Warranty period                   1 year                
Research and development                     441,593,000         303,719,000 233,810,000  
Cash surrender value of corporate-owned life insurance policies     8,398,000     7,558,000       $ 8,398,000 $ 8,398,000 $ 8,398,000 $ 8,398,000 $ 8,398,000 $ 8,398,000 7,558,000    
Revision                                    
Summary Of Significant Accounting Policy [Line Items]                                    
Decrease in revenue       863,000 865,000 1,766,000 323,000 1,901,000 (1,298,000)             2,692,000 2,792,000  
Decrease in net income       (676,000) (134,000) 210,000 (1,912,000) 906,000 (760,000)             (1,556,000) 209,000  
Selling, general and administrative       1,537,000 (1,594,000) 167,000 (922,000) (614,000) (621,000)             (1,990,000) $ (2,245,000)  
Error Correction, Other                                    
Summary Of Significant Accounting Policy [Line Items]                                    
Decrease in revenue     5,100,000                              
Decrease in net income     $ 3,700,000                              
Chief Executive Officer                                    
Summary Of Significant Accounting Policy [Line Items]                                    
Number of award tranches | tranche   12                                
Service Based Restricted Stock Unit                                    
Summary Of Significant Accounting Policy [Line Items]                                    
Expiration period                   10 years                
Performance Shares | Chief Executive Officer                                    
Summary Of Significant Accounting Policy [Line Items]                                    
Performance shares authorized (in shares) | shares   6,400,000                                
Performance Based Restricted Stock Unit                                    
Summary Of Significant Accounting Policy [Line Items]                                    
Expiration period                   10 years                
eXponential Stock Units | 2024 Employee XSP                                    
Summary Of Significant Accounting Policy [Line Items]                                    
Number of award tranches | tranche 7                                  
Independent vesting conditions | condition     3             3 3 3 3 3 3      
Risk-free interest rate, minimum (as percentage)                             3.60%      
Risk-free interest rate, maximum (as percentage)                             4.50%      
Expected volatility, minimum (as percentage)                             41.00%      
Expected volatility, maximum (as percentage)                             46.80%      
Expected dividend rate                             0.00%      
Weighted-average expected volatility                             41.60%      
2027 Notes                                    
Summary Of Significant Accounting Policy [Line Items]                                    
Interest rate (as a percent)     0.50%             0.50% 0.50% 0.50% 0.50% 0.50% 0.50%   0.50%  
Advertising                                    
Summary Of Significant Accounting Policy [Line Items]                                    
Selling, general and administrative                     $ 4,400,000         1,900,000 $ 2,300,000  
Net sales from products                                    
Summary Of Significant Accounting Policy [Line Items]                                    
Decrease in revenue       (292,763,000) (270,424,000) (256,439,000) (255,055,000) (233,688,000) (218,820,000)   $ (1,221,292,000)         (964,002,000) (797,177,000)  
Net sales from products | Revision                                    
Summary Of Significant Accounting Policy [Line Items]                                    
Decrease in revenue       $ 2,422,000 $ 1,624,000 $ 1,966,000 $ 1,388,000 $ (214,000) $ 569,000             $ 3,709,000 $ 4,211,000  
Minimum | Performance Based Restricted Stock Unit                                    
Summary Of Significant Accounting Policy [Line Items]                                    
Vesting period                   1 year                
Minimum | eXponential Stock Units | 2024 Employee XSP                                    
Summary Of Significant Accounting Policy [Line Items]                                    
Expected life of options                   8 years                
Maximum                                    
Summary Of Significant Accounting Policy [Line Items]                                    
Remaining terms     12 years             12 years 12 years 12 years 12 years 12 years 12 years      
Maximum | Performance Based Restricted Stock Unit                                    
Summary Of Significant Accounting Policy [Line Items]                                    
Vesting period                   8 years                
Maximum | eXponential Stock Units | 2024 Employee XSP                                    
Summary Of Significant Accounting Policy [Line Items]                                    
Expected life of options                   8 years 7 months 6 days